IGM Biosciences Ownership | Who Owns IGM Biosciences?


OverviewForecastRevenueFinancialsChart

IGM Biosciences Ownership Summary


IGM Biosciences is owned by 35.53% institutional investors, 35.05% insiders, and 29.42% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 6.80% of IGMS shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.99% of its assets in IGM Biosciences shares.

IGMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIGM Biosciences35.53%35.05%29.42%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp4.09M6.80%$28.10M
Price t rowe associates inc /md/4.08M6.78%$28.00M
Artal group3.33M5.54%$22.88M
Redmile group3.07M5.11%$21.11M
Goldman sachs group1.33M2.22%$9.16M
Blackrock883.08K1.47%$6.07M
Vanguard group878.62K1.46%$6.04M
Fmr818.87K1.36%$5.63M
State street457.62K0.76%$3.14M
Geode capital management367.68K0.61%$2.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group3.07M1.28%$21.11M
Artal group3.33M0.58%$22.88M
Baker bros. advisors lp4.09M0.36%$28.10M
Corton capital63.34K0.23%$435.12K
Bruce100.00K0.23%$687.00K
Eagle bay advisors44.63K0.17%$272.72K
Rhenman & partners asset management ab195.00K0.13%$1.34M
Virtus etf advisers11.40K0.04%$78.33K
Gsa capital partners llp61.98K0.03%$426.00K
Quest partners11.91K0.01%$81.84K

Top Buyers

HolderShares% AssetsChange
Artal group3.33M0.58%250.00K
Price t rowe associates inc /md/4.08M0.00%187.07K
State street457.62K0.00%138.35K
Blackrock883.08K0.00%125.12K
Corton capital63.34K0.23%63.34K

Top Sellers

HolderShares% AssetsChange
Ra capital management---937.50K
Fmr818.87K0.00%-498.47K
Samsara biocapital---154.66K
Marshall wace, llp---107.27K
Jacobs levy equity management---78.58K

New Positions

HolderShares% AssetsChangeValue
Corton capital63.34K0.23%63.34K$435.12K
Millennium management30.00K0.00%30.00K$206.10K
Susquehanna group, llp12.60K-12.60K$86.56K
Aqr capital management12.23K0.00%12.23K$84.02K
Corebridge financial8.16K0.00%8.16K$56.07K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Advisor group-59.00
Quarry lp-197.00
Hanseatic management services-366.00
Nbc securities-450.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202478-8.24%21,552,420-3.19%352.59%34-35.85%2566.67%
Jun 30, 202485-3.41%22,262,728-2.42%372.55%5310.42%15-28.57%
Mar 31, 20248818.92%22,815,5464.28%382.83%4829.73%21-
Dec 31, 202374-8.64%21,879,400-1.96%361.50%37-11.90%21-4.55%
Sep 30, 202381-1.22%22,316,9700.26%491.97%42-25.00%2229.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
US Small-Cap Growth II Equity Comp1.78M2.99%-189.87K
T. Rowe Price New Horizons1.78M2.99%-
T. Rowe Price Health Sciences829.52K1.40%-27.74K
Fidelity Select Biotechnology605.81K1.02%-204.17K
Vanguard Total Stock Mkt Idx Inv448.61K0.75%-
T. Rowe Price New Horizons Tr-Z426.94K0.72%30.79K
iShares Russell 2000 ETF419.34K0.71%-1.60K
Vanguard Institutional Extnd Mkt Idx Tr275.55K0.46%-
Invesco Dorsey Wright SmallCap Momt ETF224.31K0.38%406.00
State St Russell Sm/Mid Cp® Indx NL Cl C194.39K0.33%-1.90K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 15, 2025Weber Steven PRINCIPAL ACCOUNTING OFFICERSell$1.91K
Dec 16, 2024Weber Steven PRINCIPAL ACCOUNTING OFFICERSell$4.03K
Dec 16, 2024Decker Lisa Lynn CHIEF BUSINESS OFFICERSell$7.95K
Dec 16, 2024Harler Mary Beth Chief Executive OfficerSell$12.78K
Dec 16, 2024Tahir Misbah CHIEF FINANCIAL OFFICERSell$12.78K

Insider Transactions Trends


DateBuySell
2024 Q4-4
2024 Q3-8
2024 Q2-7
2024 Q1812
2023 Q41210

IGMS Ownership FAQ


Who Owns IGM Biosciences?

IGM Biosciences shareholders are primarily institutional investors at 35.53%, followed by 35.05% insiders and 29.42% retail investors. The average institutional ownership in IGM Biosciences's industry, Biotech Stocks , is 109.70%, which IGM Biosciences falls below.

Who owns the most shares of IGM Biosciences?

IGM Biosciences’s largest shareholders are Baker bros. advisors lp (4.09M shares, 6.80%), Price t rowe associates inc /md/ (4.08M shares, 6.78%), and Artal group (3.33M shares, 5.54%). Together, they hold 19.12% of IGM Biosciences’s total shares outstanding.

Does Blackrock own IGM Biosciences?

Yes, BlackRock owns 1.47% of IGM Biosciences, totaling 883.08K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.07M$. In the last quarter, BlackRock increased its holdings by 125.12K shares, a 16.51% change.

Who is IGM Biosciences’s biggest shareholder by percentage of total assets invested?

Redmile group is IGM Biosciences’s biggest shareholder by percentage of total assets invested, with 1.28% of its assets in 3.07M IGM Biosciences shares, valued at 21.11M$.

Who is the top mutual fund holder of IGM Biosciences shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of IGM Biosciences shares, with 2.99% of its total shares outstanding invested in 1.78M IGM Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools